Xenon Pharmaceuticals Inc. (XENE) Social Stream



Xenon Pharmaceuticals Inc. (XENE): $38.89

1.96 (+5.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add XENE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 381

in industry

XENON PHARMACEUTICALS INC (XENE) Price Targets From Analysts

Use the tables below to see what analysts covering XENON PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-28 8 $50 $34 $44.857 $36.39 23.27%
2022-01-23 7 $50 $40 $45.857 $36.39 26.02%
2022-03-02 8 $50 $40 $45.857 $36.39 26.02%
2022-06-22 8 $50 $40 $46 $36.39 26.41%
2022-07-21 9 $60 $40 $47.625 $36.39 30.87%
2022-08-10 9 $60 $40 $49 $36.39 34.65%
2022-08-11 9 $60 $46 $50.75 $36.39 39.46%
2022-09-17 10 $60 $46 $50.75 $36.39 39.46%
2022-10-13 9 $60 $46 $51.125 $36.39 40.49%
2022-10-19 10 $60 $46 $51.222 $36.39 40.76%
2022-11-09 10 $60 $35 $49.333 $36.39 35.57%
2022-11-11 11 $60 $46 $50.4 $36.39 38.5%
2022-11-14 11 $60 $46 $50.2 $36.39 37.95%
2022-11-28 12 $60 $46 $50.181 $36.39 37.9%

The Trend in the Analyst Price Target


XENE's average price target has moved up $5.32 over the prior 13 months.

Over the past 51 weeks, XENE's average upside potential has been 46.21%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-02 8 50 40 46.000 32.74 40.5%
2022-09-10 10 60 46 50.444 37.53 34.41%
2022-09-17 9 60 46 50.750 37.31 36.02%
2022-10-13 9 60 46 51.125 36.13 41.5%
2022-10-19 10 60 46 51.222 35.12 45.85%

XENE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.17 10 2 0 0 0 12

The Trend in the Broker Recommendations


XENE's average broker recommendation rating improved by 0.07 over the prior 35 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of Pharmaceutical Products stocks, XENON PHARMACEUTICALS INC's variance in analysts' estimates is lower than -200.12% of them.
  • XENON PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 312.9% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, XENON PHARMACEUTICALS INC's number of analysts covering the stock is higher than 1156.03% of them.
  • In terms of how XENON PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 1104.65% of that group.

Stocks similar to XENON PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CMRX, TGTX, and NKTX.

What is the outlook for XENE? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6194 seconds.